AHAtieh Hashemi

Atieh Hashemi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Atieh Hashemi has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Aidin Behravan

    Department of Pharmaceutical Biotechnology, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran

    7 shared publications
  • Gilar Gorji-Bahri

    Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Fahimeh Baghbani-Arani

    Department of Genetics and Biotechnology, School of Biological Science, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran

    5 shared publications
  • Hamid Reza Moghimi

    Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Majid Basafa

    Department of Pharmaceutical Biotechnology, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran

    4 shared publications
  • Gilar Gorji-Bahri

    Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran

    3 shared publications

Latest Publications

  • Improved Extracellular Level of L-Asparaginase in Shaken Cultures of Escherichia coli ATCC 11,303 Using a Statistical Design Approach

    by Negar Bozorgchami, Hossein Vahidi, Atieh Hashemi, Reyhaneh Varshochian, Mohammad Reza Khoshayand

    Direct purification of a protein from the culture medium is usually the simplest and most cost-effective method, so maximizing extracellular yield is one of the most important goals in protein supply. Although L-asparaginase is not naturally secreted into the extracellular medium through conventional cellular secretory pathways in Escherichia coli, some proteins were previously shown to be released from periplasm of E. coli into medium depending on culture medium and aeration efficiency. Here, extracellular release of L-asparaginase into the culture medium by the E. coli ATCC 11303 was demonstrated and found to be strongly dependent on medium composition, aeration effectiveness, and their interaction. Employing the RSM-CCD (response surface methodology- central composite design), the impacts of four independent factors (shaking speed, maltose, tryptone, and L-asparagine concentrations) on extracellular L-asparaginase activity were also investigated. Optimization of the culture medium led to a significant increase in extracellular L-asparaginase activity, closely matching the predicted values and confirming the robustness of the model. Although further studies appear necessary, this investigation highlights the practical importance of aeration and culture medium composition in extracellular release of L-asparaginase.

  • Open Access

    Enhanced anti-EpCAM ScFv production and reduced acetate overflow in a BW25113-derived E. coli strain with ArcA and Pka deletions

    by Majid Basafa, Aidin Behravan, Hossein Vahidi, Atieh Hashemi

    Escherichia coli strains are widely utilized as cell factories for recombinant protein production. However, acetate overflow remains a significant challeng


  • Optimizing Gene Sources for L-asparaginase Production: A Comparative Review

    by Vida Ebrahimi, Atieh Hashemi

    L-asparaginase is a versatile enzyme that has been a vital tool in both cancer treatment and food production. In the clinic, it’s used as a first-line treatment for acute lymphoblastic leukemia. That’s because it can deplete the extracellular L-asparagine that cancer cells need to multiply. In the food industry, it helps reduce the formation of acrylamide in starchy foods that are cooked at high heat. That makes food safer for consumers. The enzyme’s performance depends heavily on where its genes come from. That source affects how well it works, how stable it is, how likely it is to trigger an immune response-and how feasible it is to produce. To evaluate the best gene sources for L-asparaginase, this review scoured the major biomedical databases. It fills a gap in existing research by systematically assessing gene sources based on their suitability for different applications: cancer therapy, food safety and biosensing. By matching gene selection with the needs of downstream applications, this review shows how application-driven gene sourcing can lead to safer, more effective and more viable L-asparaginase variants. That approach gives us new insights to guide the next generation of biotech and clinical advancements in enzyme design and deployment.

  • Open Access

    Recombinant Expression of Single-Chain Variable Fragment Antibody: A Comparative Study of Growth Medium Effects

    by Mobina Mansourian, Atieh Hashemi, Majid Basafa

    Background: Monoclonal antibodies (mAbs) play an important role in immunotherapy by targeting specific antigens and more effectively attacking cancer cells. Antibody fragments, such as single-chain variable fragments (scFvs), can offer several advantages over whole antibodies, including better tumor penetration and tissue clearance, fewer side effects, and easier recombinant production. Cell growth, protein production, and solubility in microbial cell factories have been found to be significantly affected by the composition of the growth medium. Improved solubility reduces aggregation challenges, leading to greater recovery of functional protein and reduced purification costs. Therefore, changing the type of culture medium can be considered a strategy to achieve higher yields of functional recombinant proteins. Objectives: Here, we investigated the influence of various culture media on the expression of scFvs derived from 4D5MOC-B, a mAb that binds to epithelial cell adhesion molecule (EpCAM), a biologically important marker for tumor immunotherapy. Methods: A genetically engineered Escherichia coli strain was employed to test the effect of four general media, including luria bertani (LB), terrific broth (TB), yeast tryptone 2x (TY2x), and minimal medium (M9), on cell density, scFv yield, and protein solubility. The experiments were conducted in duplicates for each medium. Data were presented as mean ± SD. Statistical analysis was conducted using one-way analysis of variance (ANOVA), followed by the Tukey post-test for pairwise comparisons. Results: The highest protein level was obtained in TB medium (215.19 ± 3.27 µg/mL), approximately 8-fold higher than that produced in M9 (26.83 ± 1.38 µg/mL). The maximum cell density of recombinant E. coli (10.89 ± 0.84) was achieved in TB after 22 hours. Shorter lag phases and higher cell densities in nutrient-rich media demonstrate how nutrient availability influences bacterial growth dynamics. Moreover, TY2x showed the highest soluble-to-insoluble protein ratio, 1.117 ± 0.048, followed by TB (0.926 ± 0.013), LB (0.883 ± 0.004), and M9 (0.662 ± 0.013). Conclusions: The present study highlights the importance of selecting a suitable culture medium for the promotion of recombinant protein synthesis in microbial systems. We also underline the potential industrial implications of using TB for high-density cultivation and reduced production costs.


  • Open Access

    Engineered Escherichia coli with Superior Recombinant Protein Production and Reduced Acetate Overflow Compared with Industrial Strains

    by Majid Basafa, Aidin Behravan, Hossein Vahidi, Atieh Hashemi

    Background: Escherichia coli strains are widely used as cell factories for recombinant protein production. Among these, E. coli BL21 is often preferred over K‑12 strains due to its lower acetate yield and higher biomass production. However, acetate overflow remains a significant challenge, negatively affecting both biomass yield and protein expression. Previous studies have shown that coordinated activation of the TCA cycle and the PTA‑ACS node via deletion of pka and arcA in E. coli K‑12 BW25113 can reduce acetate excretion fourfold. Results: Here, we evaluated an E. coli K‑12 BW25113 strain with pka and arcA deletions for the expression of single-chain variable fragments (scFvs) derived from 4D5MOC-B, a monoclonal antibody binding to epithelial cell adhesion molecule (EpCAM), a key target in tumor immunotherapy. The engineered strain, RV04 (BW25113 ΔpkaΔarcA), demonstrated superior growth compared to BW25113 and BL21. In the minimal M9 medium, RV04 reached a maximum cell density 44% higher than the wild type and 11% higher than BL21. In enriched M9 medium, it achieved a μ_max of 0.775 ± 0.003 h⁻¹ and a maximum cell density of 2.1095 ± 0.0205, even under metabolic burden. While the wild type accumulated up to 3.99 g/L of acetate without reuptake, RV04 completely eliminated acetate in M9 medium and resisted its accumulation even when the glucose concentration was tripled. Under these conditions, RV04 maintained acetate levels comparable to BW25113 in standard M9 while supporting higher cell density and protein production. These optimizations resulted in significantly enhanced recombinant protein production. In LB medium, RV04 produced 5% more protein than BL21 and 44.8% more than the wild type, while in enriched M9 medium, it outperformed BL21 and BW25113 by 7.1% and 59.5%, respectively. Furthermore, RV04 presented markedly greater protein expression than did the other commercial strains; RV04 produced 33.8% more protein than Shuffle, 145.7% more than Origami, and over tenfold more than Rosetta. Conclusions: Our findings demonstrate that the BW25113 ΔpkaΔarcA effectively mitigates acetate overflow, enhances growth, and substantially increases recombinant protein yield, making RV04 a strong candidate for large-scale industrial bioprocesses.

  • Open Access

    Enhancement effect of urea toward electroporation-mediated plasmid transfection efficiency in the HEK-293 cell line

    by Mahshid Mowla, Gilar Gorji-Bahri, Hamid Reza Moghimi, Atieh Hashemi

    Intracellular delivery is crucial in biological and medical studies. Although many molecular tools have been created for cell-based gene therapies, it remains challenging to introduce external molecules into cells. As one of the most popular non-viral transfection methods, electroporation induces transient pores in the cell membrane by applying an external electric field. Unsatisfactory transfection efficiency and low cell viability are the major drawbacks of electroporation. To overcome these issues, the current study investigated the effect of urea on electroporation-mediated transfection efficiency. Experimental approach: Three voltages of electroporation, including 100, 120, and 140 V, and 3 concentrations of urea buffer, including 0.25%, 0.5%, and 1% W/V, were considered as variables in this study. The HEK-293 cell line was used for transfection, and green fluorescent protein (GFP) expression was evaluated using flow cytometry and fluorescence microscopy. Findings/Results: The results showed that the combination of electroporation and urea increased electroporation efficacy, but the effect depended on voltage and urea concentration. When different concentrations of urea were added to HEK-293 cells at a voltage of 100 V, the number of cells transfected by pEGFP-N1 increased (from 12.3 ± 0.2% in untreated cells to 17.35 ± 0.55%, 23.3 ± 0.3%, and 14 ± 0.1% at urea concentrations of 0.25%, 0.5%, and 1% W/V, respectively). The electroporation buffer containing 0.5% W/V urea showed the highest EGFP expression (23.3 ± 0.3%) and high cell viability (over 90%). Conclusion and implications: This research offers a new perspective for improving gene transfection efficiency once electroporation is utilized.

  • Open Access

    CRISPR-based gene editing in plants: Focus on reagents and their delivery tools

    by Vida Ebrahimi, Atieh Hashemi

    Introduction: CRISPR-Cas9 technology has revolutionized plant genome editing, providing precise and efficient methods for genetic modification. This study focuses on the advancements and delivery of CRISPR-Cas9 in plant gene editing. Methods: A comprehensive search in scientific databases, including PubMed, ScienceDirect, and Google Scholar, was conducted to gather information on CRISPR-Cas9 gene editing and its delivery in precise gene modification in plants. Results: The evolving landscape of CRISPR nucleases has led to the development of innovative technologies, enhancing plant research. However, successful editing is contingent on efficient delivery of genome engineering reagents. CRISPR-based gene editing in plants utilizes diverse delivery methods: Agrobacterium-mediated transformation for bacterial transfer, biolistic transformation for physical gene insertion, electroporation for direct gene entry, expression of developmental regulators for gene expression modulation, and tobacco rattle virus as a viral vector, each offering distinct advantages for precise and efficient genetic modification in plants. Conclusion: CRISPR-Cas9 gene editing stands as a pivotal advancement in plant genetics, offering precise gene manipulation with applications in agriculture and biotechnology. The continuous refinement of reagent delivery tools reinforces CRISPR-Cas9's transformative role in plant genome editing, with significant implications for broader scientific applications.


  • Optimizing recombinant antibody fragment production: A comparison of artificial intelligence and statistical modeling

    by Majid Basafa, Atieh Hashemi, Aidin Behravan

    Maximizing the recombinant protein yield necessitates optimizing the production medium. This can be done using a variety of methods, including the conventional “one‐factor‐at‐a‐time” approach and more recent statistical and mathematical methods such as artificial neural network (ANN), genetic algorithm, etc. Every approach has advantages and disadvantages of its own, yet even when a technique has flaws, it is nevertheless used to get the best results. Here, one categorical variable and four numerical parameters, including post‐induction time, inducer concentration, post‐induction temperature, and pre‐induction cell density, were optimized using the 232 experimental assays of the central composite design. The direct and indirect effects of factors on the yield of anti‐epithelial cell adhesion molecule extracellular domain fragment antibody were examined using statistical methods. The analysis of variance results indicate that the response surface methodology (RSM) model is effective in predicting the amount of produced single‐chain fragment variable ( p ‐value = 0.0001 and R 2 = 0.905). For ANN modeling, the evaluation using normalized root mean square error (NRMSE) and R 2 values shows a good fit ( R 2 = 0.942) and accurate predictions (NRMSE = 0.145). The analysis of error parameters and R 2 of a dataset, which contained 30 data points randomly selected from the complete dataset, showed that the ANN model had a higher R 2 value (0.968) compared to the RSM model (0.932). Furthermore, the ANN model demonstrated stronger predictive ability with a lower NRMSE (0.048 vs. 0.064). Induction at the cell density of 0.7 and an isopropyl β‐D‐1‐thiogalactopyranoside concentration of 0.6 mM for 32 h at 30°C in BW25113 was the ideal culture condition leading to the protein yield of 259.51 mg/L. Under the optimum conditions, the output values predicted by the ANN model (259.83 mg/L) were more in line with the experimental data (259.51 mg/L) than the RSM (276.13 mg/L) expected value. This outcome demonstrated that the ANN model outperforms the RSM in terms of prediction accuracy.


  • Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology

    by Vida Ebrahimi, Atieh Hashemi

    L-asparaginase is an essential enzyme used in cancer treatment, but its production faces challenges like low yield, high cost, and immunogenicity. Recombinant production is a promising method to overcome these limitations. In this study, response surface methodology (RSM) was used to optimize the production of L-asparaginase 1 from Saccharomyces cerevisiae in Escherichia coli K-12 BW25113. The Box-Behnken design (BBD) was utilized for the RSM modeling, and a total of 29 experiments were conducted. These experiments aimed to examine the impact of different factors, including the concentration of isopropyl-b-LD-thiogalactopyranoside (IPTG), the cell density prior to induction, the duration of induction, and the temperature, on the expression level of L-asparaginase 1. The results revealed that while the post-induction temperature, cell density at induction time, and post-induction time all had a significant influence on the response, the post-induction time exhibited the greatest effect. The optimized conditions (induction at cell density 0.8 with 0.7 mM IPTG for 4 h at 30 °C) resulted in a significant amount of L-asparaginase with a titer of 93.52 μg/mL, which was consistent with the model-based prediction. The study concluded that RSM optimization effectively increased the production of L-asparaginase 1 in E. coli, which could have the potential for large-scale fermentation. Further research can explore using other host cells, optimizing the fermentation process, and examining the effect of other variables to increase production.